The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Reducing The Risk Of Cardiovascular Events In A Subject - EP4056176

The patent EP4056176 was granted to Amarin Pharmaceuticals Ireland on Apr 24, 2024. The application was filed on Apr 22, 2019 under application number EP22171033A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4056176

AMARIN PHARMACEUTICALS IRELAND
Application Number
EP22171033A
Filing Date
Apr 22, 2019
Status
Granted And Under Opposition
Mar 22, 2024
Publication Date
Apr 24, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ELKINGTON AND FIFEJan 24, 2025ELKINGTON AND FIFEADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONUS2007185198
OPPOSITIONUS2010311834
OPPOSITIONUS2018153846
SEARCHUS2007185198
SEARCHUS2010311834
SEARCHUS2018153846

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents